A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.
Penson RT, Campos SM, Seiden MV, Krasner C, Fuller AF Jr, Goodman A, Roche M, Willman A, Muzikansky A, Matulonis UA; Gynecologic Oncology Research Program at Dana Farber/Partners CancerCare.
Penson RT, et al. Among authors: goodman a.
Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1035-41. doi: 10.1111/j.1525-1438.2005.00482.x.
Int J Gynecol Cancer. 2005.
PMID: 16343179
Free article.
Clinical Trial.